Kymera Therapeutics, Inc.KYMRNASDAQ
Loading
Debt to Equity Over TimeElevated
Percentile Rank57
3Y CAGR+13.8%
5Y CAGR-3.9%
Year-over-Year Change
Debt-to-equity ratio
3Y CAGR
+13.8%/yr
Annual compound
5Y CAGR
-3.9%/yr
Recent acceleration
Percentile
P57
Within normal range
vs 5Y Ago
0.8x
Contraction
Streak
2 yr
Consecutive declineElevated
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 0.05 | -50.4% |
| 2024 | 0.11 | -51.0% |
| 2023 | 0.21 | +506.2% |
| 2022 | 0.04 | -9.5% |
| 2021 | 0.04 | -38.3% |
| 2020 | 0.06 | +122.3% |
| 2019 | -0.28 | -1311.3% |
| 2018 | -0.02 | - |